Literature DB >> 25480416

Overexpression of Numb suppresses growth, migration, and invasion of human clear cell renal cell carcinoma cells.

Jin Sima1, Bao Zhang, Yuanzi Yu, Xinyuan Sima, Yanxin Mao.   

Abstract

The objective of the study was to investigate the impact of Numb on cell growth, cell migration, and invasion in human clear cell renal cell carcinoma (ccRCC). Endogenous expression of Numb was evaluated in the ccRCC cell lines (786-O, Caki-1, and Caki-2) and control reference human renal proximal tubular epithelial cells. Numb expression was decreased in the ccRCC cells compared with the control cells (P < 0.01). Then, 786-O and Caki-1 cells described as suitable transfection hosts were used in transfection to carry out biological function studies. The three experimental groups were as follows: Numb-ORF (transfected with Numb-ORF plasmid), blank-vector (transfected with pCMV6-entry), and cell-alone group (no DNA). Numb expression in the Numb-ORF groups was significantly higher than that in the controls (P < 0.01). Cell growth was remarkably reduced (P < 0.01), and the number of migrating or invading cells was reduced (P < 0.01) in the Numb-ORF groups compared with controls. Furthermore, the ratio of G0/G1 phase in the Numb-ORF group of 786-O cells was increased, and the S phase fraction and proliferation index was decreased (P < 0.01). Cyclin D1 and MMP-9 expression was reduced in the Numb-ORF groups compared with controls. Here, we have provided data for attenuated Numb expression in the ccRCC cells. Overexpression of Numb could induce G0/G1 phase arrest and inhibit cell proliferation, migration, and invasion. The suppressive effects might be due to downregulation of cyclin D1 or MMP-9 expression. Taken together, our data suggest that Numb may possibly function as a tumor suppressor involved in the carcinogenesis of ccRCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25480416     DOI: 10.1007/s13277-014-2918-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  35 in total

1.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 2.  The multiple functions of Numb.

Authors:  Alberto Gulino; Lucia Di Marcotullio; Isabella Screpanti
Journal:  Exp Cell Res       Date:  2009-11-26       Impact factor: 3.905

3.  TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor.

Authors:  Hui Li; Yi Zhang; Yue Zhang; Xue Bai; Yang Peng; Ping He
Journal:  Tumour Biol       Date:  2014-02-25

4.  BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer.

Authors:  Fen Hu; Xiangzhi Meng; Qi Tong; Lin Liang; Rong Xiang; Tianhui Zhu; Shuang Yang
Journal:  Biochim Biophys Acta       Date:  2013-09-06

5.  Sorafenib in advanced clear-cell renal-cell carcinoma.

Authors:  Bernard Escudier; Tim Eisen; Walter M Stadler; Cezary Szczylik; Stéphane Oudard; Michael Siebels; Sylvie Negrier; Christine Chevreau; Ewa Solska; Apurva A Desai; Frédéric Rolland; Tomasz Demkow; Thomas E Hutson; Martin Gore; Scott Freeman; Brian Schwartz; Minghua Shan; Ronit Simantov; Ronald M Bukowski
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

6.  Alterations of the Notch pathway in lung cancer.

Authors:  Britta Westhoff; Ivan N Colaluca; Giovanni D'Ario; Maddalena Donzelli; Daniela Tosoni; Sara Volorio; Giuseppe Pelosi; Lorenzo Spaggiari; Giovanni Mazzarol; Giuseppe Viale; Salvatore Pece; Pier Paolo Di Fiore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

7.  Characterization of Numb expression in astrocytomas.

Authors:  Benedict Yan; Feroz Mohd Omar; Kakoli Das; Wai Hoe Ng; Chinghway Lim; Koh Shiuan; Celestial T Yap; Manuel Salto-Tellez
Journal:  Neuropathology       Date:  2008-03-31       Impact factor: 1.906

Review 8.  Renal cell carcinoma.

Authors:  Brian I Rini; Steven C Campbell; Bernard Escudier
Journal:  Lancet       Date:  2009-03-05       Impact factor: 79.321

9.  Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells.

Authors:  Sen Wei; Chunfang Hao; Xin Li; Honglin Zhao; Jun Chen; Qinghua Zhou
Journal:  Tumour Biol       Date:  2012-03-06

10.  Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis.

Authors:  Salvatore Pece; Michela Serresi; Elisa Santolini; Maria Capra; Esther Hulleman; Viviana Galimberti; Stefano Zurrida; Patrick Maisonneuve; Giuseppe Viale; Pier Paolo Di Fiore
Journal:  J Cell Biol       Date:  2004-10-18       Impact factor: 10.539

View more
  7 in total

1.  Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb.

Authors:  Chen Shao; Zhiguo Li; Nihal Ahmad; Xiaoqi Liu
Journal:  Cell Cycle       Date:  2017-04-24       Impact factor: 4.534

2.  Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation.

Authors:  Maretoshi Hirai; Yoh Arita; C Jane McGlade; Kuo-Fen Lee; Ju Chen; Sylvia M Evans
Journal:  J Clin Invest       Date:  2017-01-09       Impact factor: 14.808

3.  Predictive values of Notch signalling in renal carcinoma.

Authors:  Dorota Jędroszka; Magdalena Orzechowska; Andrzej K Bednarek
Journal:  Arch Med Sci       Date:  2017-01-31       Impact factor: 3.318

4.  NUMB and NUMBL differences in gene regulation.

Authors:  José Manuel García-Heredia; Amancio Carnero
Journal:  Oncotarget       Date:  2018-01-11

5.  The Expression and Function of NUMB in Endometrial Cancer and the Interaction with HDM2 and P53.

Authors:  Chao Wang; Weiwei Feng; Chuyao Zhang
Journal:  J Cancer       Date:  2015-08-29       Impact factor: 4.207

6.  Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy.

Authors:  José M García-Heredia; Eva M Verdugo Sivianes; Antonio Lucena-Cacace; Sonia Molina-Pinelo; Amancio Carnero
Journal:  Oncotarget       Date:  2016-09-27

7.  Numb and Numblike regulate sarcomere assembly and maintenance.

Authors:  Baolei Wang; Min Yang; Shujuan Li
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 19.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.